|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 292.01 USD | -1.79% |
|
-1.19% | -17.24% |
| 07-14 | United Therapeutics Offers Favorable Profile Ahead of Key Data, Oppenheimer Says | MT |
| 06-30 | United Therapeutics' Tyvaso to Benefit from Q2 Seasonality, UBS Says | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 328.4 | 328.4 | 339.12 |
| Spread/Res. | -11.08% | -11.08% | -13.89% |
| Spread/Supp. | +5.62% | +5.62% | +3.86% |
| Support | 276.47 | 276.47 | 281.16 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- UTHR Stock
- Charts United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition